These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30189807)

  • 21. Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products.
    García-Arieta A; Morales-Alcelay S; Herranz M; de la Torre-Alvarado JM; Blázquez-Pérez A; Suárez-Gea ML; Alvarez C
    Int J Pharm; 2012 Feb; 423(2):321-5. PubMed ID: 22120644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On assessing bioequivalence and interchangeability between generics based on indirect comparisons.
    Zheng J; Chow SC; Yuan M
    Stat Med; 2017 Aug; 36(19):2978-2993. PubMed ID: 28497561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of generics in transplantation.
    Masri MA; Andrysek T; Matha V
    Transplant Proc; 2003 Nov; 35(7):2745-7. PubMed ID: 14612102
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetic bioequivalence crossover study of branded generic and innovator formulations of the cholesterol lowering agent ezetimibe.
    Palmer JL; Kunhihitlu A; Costantini A; Esquivel F; Roush J; Edwards K; Hill TW
    Clin Pharmacol Drug Dev; 2014 May; 3(3):242-8. PubMed ID: 27128615
    [No Abstract]   [Full Text] [Related]  

  • 25. Global Harmonization of Comparator Products for Bioequivalence Studies.
    Gwaza L; Gordon J; Leufkens H; Stahl M; García-Arieta A
    AAPS J; 2017 May; 19(3):603-606. PubMed ID: 28265983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on the bioequivalence and therapeutic equivalence of generic formulations: An overview of the landscape.
    Perry R
    Clin Ther; 2010 Sep; 32(10):1796-7. PubMed ID: 21194603
    [No Abstract]   [Full Text] [Related]  

  • 27. Quality and equivalence of topical products: A critical appraisal.
    Miranda M; Cardoso C; Vitorino C
    Eur J Pharm Sci; 2020 May; 148():105082. PubMed ID: 31626969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
    Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
    AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the bioequivalence.
    vanderVaart S; Hogan ME; Einarson TR
    Clin Ther; 2010 Feb; 32(2):398, author reply 399; discussion p 399-400. PubMed ID: 20206799
    [No Abstract]   [Full Text] [Related]  

  • 30. The therapeutic equivalence of complex drugs.
    Schellekens H; Klinger E; Mühlebach S; Brin JF; Storm G; Crommelin DJ
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):176-83. PubMed ID: 20951177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximizing the Role of Physiologically Based Oral Absorption Modeling in Generic Drug Development.
    Mitra A
    Clin Pharmacol Ther; 2019 Feb; 105(2):307-309. PubMed ID: 30261093
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA mulls changes to bioequivalence standards.
    Traynor K
    Am J Health Syst Pharm; 2010 Jun; 67(11):864. PubMed ID: 20484205
    [No Abstract]   [Full Text] [Related]  

  • 34. Generic topiramate for migraine prevention: is bioequivalence the same as therapeutic equivalence?
    Evans RW
    Headache; 2009; 49(10):1545-6. PubMed ID: 19751365
    [No Abstract]   [Full Text] [Related]  

  • 35. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
    Bialer M; Midha KK
    Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence of topical generic products. Part 2. Paving the way to a tailored regulatory system.
    Miranda M; Sousa JJ; Veiga F; Cardoso C; Vitorino C
    Eur J Pharm Sci; 2018 Sep; 122():264-272. PubMed ID: 29981406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence of metered-dose inhaled medications.
    Wong BJ; Hargreave FE
    J Allergy Clin Immunol; 1993 Sep; 92(3):373-9. PubMed ID: 8360387
    [No Abstract]   [Full Text] [Related]  

  • 38. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Withdrawal of two generic clopidogrel products in Saudi Arabia for non-bio-equivalence.
    Alsultan AS; Hakeam HA
    Ann Saudi Med; 2018; 38(3):233-234. PubMed ID: 29848943
    [No Abstract]   [Full Text] [Related]  

  • 40. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
    Quiroz J; Ting N; Wei GC; Burdick RK
    Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.